PML and glioblastoma: Finally, PML overexpression identified patients with decreased survival in TCGA-KIRC, as previously observed (Wang et al, 2023), as well as in TCGA-GBM, but not in TCGA-KIRP and TCGA-HNSC (Fig. EV1A–D).